BridgeBio prices secondary offering of 5 million shares by KKR Genetic Disorder LP
Reuters2026/08/14 11:30- BridgeBio priced an oversubscribed secondary offering of 5,000,000 common shares sold by KKR Genetic Disorder L.P.
- No shares sold by BridgeBio. No proceeds to the company.
- Offering expected to close Aug. 17, 2026, subject to customary closing conditions.
- William Blair, Goldman Sachs, KKR Capital Markets acting as joint book-running managers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
